Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Maternal sildenafil for severe fetal growth restriction (STRIDER): a multicentre, randomised, placebo-controlled, double-blind trial.
Sharp A, Cornforth C, Jackson R, Harrold J, Turner MA, Kenny LC, Baker PN, Johnstone ED, Khalil A, von Dadelszen P, Papageorghiou AT, Alfirevic Z; STRIDER group. Sharp A, et al. Among authors: cornforth c. Lancet Child Adolesc Health. 2018 Feb;2(2):93-102. doi: 10.1016/S2352-4642(17)30173-6. Epub 2017 Dec 7. Lancet Child Adolesc Health. 2018. PMID: 30169244 Free article. Clinical Trial.
Effect of sildenafil on maternal hemodynamics in pregnancies complicated by severe early-onset fetal growth restriction: planned subgroup analysis from a multicenter randomized placebo-controlled double-blind trial.
Khalil A, Sharp A, Cornforth C, Jackson R, Mousa H, Stock S, Harrold J, Turner MA, Kenny LC, Baker PN, Johnstone ED, Von Dadelszen P, Magee L, Papageorghiou AT, Alfirevic Z. Khalil A, et al. Among authors: cornforth c. Ultrasound Obstet Gynecol. 2020 Feb;55(2):198-209. doi: 10.1002/uog.20851. Ultrasound Obstet Gynecol. 2020. PMID: 31432556 Free article. Clinical Trial.
Mortality in the UK STRIDER trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction.
Sharp A, Cornforth C, Jackson R, Harrold J, Turner MA, Kenny L, Baker PN, Johnstone ED, Khalil A, von Dadelszen P, Papageorghiou AT, Alfirevic Z. Sharp A, et al. Among authors: cornforth c. Lancet Child Adolesc Health. 2019 Mar;3(3):e2-e3. doi: 10.1016/S2352-4642(19)30020-3. Epub 2019 Jan 29. Lancet Child Adolesc Health. 2019. PMID: 30704877 No abstract available.
A prediction model for short-term neonatal outcomes in severe early-onset fetal growth restriction.
Sharp A, Jackson R, Cornforth C, Harrold J, Turner MA, Kenny L, Baker PN, Johnstone ED, Khalil A, von Dadelszen P, Papageorghiou AT, Alfirevic Z. Sharp A, et al. Among authors: cornforth c. Eur J Obstet Gynecol Reprod Biol. 2019 Oct;241:109-118. doi: 10.1016/j.ejogrb.2019.08.007. Epub 2019 Aug 16. Eur J Obstet Gynecol Reprod Biol. 2019. PMID: 31499415 Clinical Trial.
The PLANES study: a protocol for a randomised controlled feasibility study of the placental growth factor (PlGF) blood test-informed care versus standard care alone for women with a small for gestational age fetus at or after 32 + 0 weeks' gestation.
Gent J, Bullough S, Harrold J, Jackson R, Woolfall K, Andronis L, Kenny L, Cornforth C, Heazell AEP, Benbow E, Alfirevic Z, Sharp A. Gent J, et al. Among authors: cornforth c. Pilot Feasibility Stud. 2020 Nov 19;6(1):179. doi: 10.1186/s40814-020-00722-x. Pilot Feasibility Stud. 2020. PMID: 33292754 Free PMC article.
Short-term outcomes of phosphodiesterase type 5 inhibitors for fetal growth restriction: a study protocol for a systematic review with individual participant data meta-analysis, aggregate meta-analysis, and trial sequential analysis.
Liauw J, Groom K, Ganzevoort W, Gluud C, McKinlay CJD, Sharp A, Mackay L, Kariya C, Lim K, von Dadelszen P, Limpens J, Jakobsen JC; STRIDER Consortium. Liauw J, et al. Syst Rev. 2021 Dec 3;10(1):305. doi: 10.1186/s13643-021-01849-5. Syst Rev. 2021. PMID: 34861900 Free PMC article.
14 results